Abstracts 2014
1. Nikitina T.P. The effectiveness of Elima gel film in comparison with standard treatment with Vitamin F99 cream in patients with palmar-plantar syndrome developed against the background of antitumor therapy: the results of a pilot multicentre study / T.P. Nikitina, I.S. Bazin, G.P. Kolesnikov, M.V. Panina, P.S., K.A. Borisov, T.I. Ionova, K.A. Kurbatova // Malignant tumours. – 2014. – Vol. 3: 196-197. (In Russian)
2. Ionova T.I. Questionnaire for a full-scale evaluation of symptoms in patients with chronic myelogenous leukemia - Csp Leuk-CML: results of a validation study / T.I. Ionova, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova // XI International Symposium "Hematopoietic Stem Cell Transplantation. Gene and Cellular Therapy", in memory of Raisa Gorbachev. (In Russian)
3. Ionova T.I. Base-line Quality of Life Impairment and Its Potential Prognostic Value in Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (AHSCT) / T.I. Ionova, V.Y. Melnichenko, D.A. Fedorenko, T.P. Nikita, E. Mochkin, K.A.Kurbatova, G. Gorodokin, A.A. Novik.// Bone Marrow Transplantation. 2014. Vol. 49 (Suppl. 1, March): 170.
4. Nikitina T.P. Comprehensive symptom profile in patients with chronic myeloid leukemia: practicability and sensitivity of the new symptom assessment tool CSP Leuk-CML / T.P. Nikitina, D.A. Fedorenko, K.A. Kurbatova, E.I. Usacheva, T.I. Ionova, G.I. Gorodokin, A.A. Novik // Haematologica. 2014 (Suppl.): B1674.
5. Ionova T.I. The value of dasatinib therapy in patients with imatinib-resistant or -intolerant chronic myeloid leukemia from physician's and patient's perspective: "real world" outcomes / T.I. Ionova, T.P. Nikitina, T.A. Gritsenko, V.L. Ivanova, G.B. Kuchma, T.V. Shnaider, I.V. Sannikova, E.I. Usacheva, D.A. Fedorenko, K.A. Kurbatova // Haematologica. 2014 (Suppl.): B1675.
6. Ionova T. The usefulness of patient treatment satisfaction questionnaire (PTSQ) in diabetes mellitus (DM) patients / T. Ionova, T. Nikitina, K. Kurbatova // Value in Health. 2014. Vol. 17 (3): A256.
7. Ionova T. Applicability of the new instrument for assessment of hypoglycemia symptoms in diabetes mellitus patients / T. Ionova, T. Nikitina, K. Kurbatova // Value in Health. 2014. Vol. 17 (3): A256.
8. Nikitina T. New antioxidant-containing topical formulation for treatment of Hand-Foot Syndrome in cancer patients: physician's and patient's perspective / T. Nikitina, T. Ionova, K. Kurbatova, I. Bazin, A. Belonogov, G. Kolesnikov, M. Panina, P. Borisov // Annals of Oncology. 2014. Vol. 25 (Suppl. 4): 517–541. doi:10.1093/annonc/mdu356.35.
9. Ionova T. Self-reporting Hand-Foot Syndrome (HFS) is practical in cancer patients with chemotherapy-induced dermatological toxicity / T. Ionova, T. Nikitina, K. Kurbatova // Quality of Life Research. 2014; 23 (Suppl. 1): 111.
10. Ionova T. Patient-centered evaluation of treatment outcomes in CML patients after 12 months of second-line treatment: quality of life and symptom burden / T. Ionova, D. Fedorenko, T. Nikitina, K. Kurbatova // Quality of Life Research. 2014; 23(Suppl. 1): 67.
11. Ionova T. I. Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician's and Patient's Perspective / T.I Ionova, T.P Nikitina, D.A Fedorenko, T.A Gritsenko, V.L Ivanova, G.B Kuchma, T.V Shnaider, I.V Sannikova, E.I. Usacheva, K.A. Kurbatova // Blood. 2014; 124 (21): А2644.
12. Nikitina T.P. Baseline Quality of Life in Chronic Phase Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Imatinib and its Potential Prognostic Value / T.P. Nikitina, D.A. Fedorenko, K.A. Kurbatova, T.A. Gritsenko, V.L. Ivanova, G.B. Kuchma, T.V. Shnaider, I.V. Sannikova, E.I. Usacheva, T.I. Ionova.// ELN Frontiers meeting. Abstracts. 2014: 21.
|